Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/10438
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ng, Steven | en |
dc.contributor.author | Butzkueven, Helmut | en |
dc.contributor.author | Kalnins, Renate M | en |
dc.contributor.author | Rowe, Christopher C | en |
dc.date.accessioned | 2015-05-15T23:53:12Z | |
dc.date.available | 2015-05-15T23:53:12Z | |
dc.date.issued | 2007-09-24 | en |
dc.identifier.citation | Journal of Clinical Neuroscience 2007; 14(11): 1126-9 | en |
dc.identifier.govdoc | 17890092 | en |
dc.identifier.other | PUBMED | en |
dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/10438 | en |
dc.description.abstract | Primary central nervous system lymphoma (PCNSL) can be associated with preceding demyelinating pseudotumoral brain lesions. The 'sentinel' demyelinating lesions recede spontaneously or with corticosteroid, and are followed by development of PCNSL typically within 12 months. This report describes a 29 year-old post-partum woman who developed PCNSL 4 years after a biopsy-proven pseudotumoral demyelinating episode. She presented with focal seizures in February 2005. She subsequently developed hemiparesis and raised intracranial pressure. MRI showed two contrast enhancing lesions in the right frontal lobe, which were hypermetabolic on (18)F-FDG PET. A provisional diagnosis of tumefactive multiple sclerosis was made. Symptoms recurred despite multiple courses of high dose corticosteroid. Brain biopsy confirmed large B-cell non-Hodgkin's lymphoma. This patient illustrates the importance of considering PCNSL in patients presenting with a space-occupying lesion, even with previously confirmed demyelination, and that the interval between the two events may be several years. | en |
dc.language.iso | en | en |
dc.subject.other | Adult | en |
dc.subject.other | Brain Neoplasms.complications.pathology.radionuclide imaging | en |
dc.subject.other | Demyelinating Diseases.complications | en |
dc.subject.other | Female | en |
dc.subject.other | Humans | en |
dc.subject.other | Lymphoma, B-Cell.complications.pathology.radionuclide imaging | en |
dc.subject.other | Lymphoma, Non-Hodgkin.complications.pathology.radionuclide imaging | en |
dc.subject.other | Magnetic Resonance Imaging | en |
dc.subject.other | Positron-Emission Tomography | en |
dc.subject.other | Pseudotumor Cerebri.complications | en |
dc.subject.other | Time Factors | en |
dc.title | Prolonged interval between sentinel pseudotumoral demyelination and development of primary CNS lymphoma. | en |
dc.type | Journal Article | en |
dc.identifier.journaltitle | Journal of Clinical Neuroscience | en |
dc.identifier.affiliation | Department of Nuclear Medicine and Centre for PET, Austin Health, 145 Studley Road, Heidelberg, Melbourne, Victoria 3084, Australia | en |
dc.identifier.doi | 10.1016/j.jocn.2006.05.003 | en |
dc.description.pages | 1126-9 | en |
dc.relation.url | https://pubmed.ncbi.nlm.nih.gov/17890092 | en |
dc.type.austin | Journal Article | en |
local.name.researcher | Rowe, Christopher C | |
item.openairetype | Journal Article | - |
item.cerifentitytype | Publications | - |
item.grantfulltext | none | - |
item.fulltext | No Fulltext | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.languageiso639-1 | en | - |
crisitem.author.dept | Molecular Imaging and Therapy | - |
Appears in Collections: | Journal articles |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.